Literature DB >> 25849334

Genetic heterogeneity of the β-globin gene in various geographic populations of Yunnan in southwestern China.

Jie Zhang1, Jing He1, Xiao-Hong Zeng1, Shi-Jun Ge2, Yu Huang3, Jie Su1, Xue-Mei Ding1, Ji-Qing Yang1, Yong-Jiu Cao1, Hong Chen1, Ying-Hong Zhang1, Bao-Sheng Zhu1.   

Abstract

OBJECTIVES: The aim of this study was to investigate the geographic distribution of β-globin gene mutations in different ethnic groups in Yunnan province.
METHODS: From 2004 to 2014, 1,441 subjects with hemoglobin disorders, identified by PCR-reverse dot blot and DNA sequencing, were studied according to ethnicity and geographic origin. Haplotypes were examined among 41 unrelated thalassemia chromosomes.
RESULTS: Eighteen β-thalassemia mutations and seven hemoglobin variants were identified for 1,616 alleles in 22 different ethnic groups from all 16 prefecture-level divisions of Yunnan. The prevalence of β-thalassemia was heterogeneous and regionally specific. CD 41-42 (-TCTT) was the most prevalent mutation in the populations of northeastern Yunnan. CD 17 (A>T) was the most common mutation in the populations of southeastern Yunnan, especially for the Zhuang minority, whereas Hb E (CD 26, G>A) was the most prevalent mutation in populations of southwestern Yunnan, especially for the Dai minority. Among the seven types of haplotypes identified, CD 17 (A>T) was mainly linked to haplotype VII (+ - - - - - +) and IVS-II-654 (C>T) was only linked to haplotype I (+ - - - - + +).
CONCLUSION: Our data underline the heterogeneity of β-globin gene mutations in Yunnan. This distribution of β-globin mutations in the geographic regions and ethnic populations provided a detailed ethnic basis and evolutionary view of humans in southern China, which will be beneficial for genetic counseling and prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25849334      PMCID: PMC4388507          DOI: 10.1371/journal.pone.0122956

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

β-thalassemia is one of the most common monogenic recessive diseases and it is the result of the presence of a mutation in one or two β-globin genes. It is characterized by decrease or absence of β-globin chain synthesis. β-thalassemia is prevalent in Mediterranean countries as well as in tropical Africa, southeast Asia and southern China. Approximately 800 different mutations of the β-globin gene have been documented in the HbVar database and more than 50 of them have been reported in China. The spectrum of β-globin gene mutations is variable within different ethnic groups. A specific racial group may have its own particular spectrum of mutations, reflecting significant genetic heterogeneity in the population. Characterizing the spectrum and frequency of β-globin gene mutations in different populations is useful for genetic counseling and prevention strategies. The mutations responsible for β-thalassemia have been well documented in southern China, especially in Guangxi [1], Hongkong [2], Hainan [3] and Guangdong province [4]. However, mutations causing thalassemia have been studied less in the populations of Yunnan province. Yunnan province, a region located in southwestern China, has the Tropic of Cancer running through its southern part and has been known as the crucial gate of southeast Asia. The territory of Yunnan is largely tropical and consists of a subtropical plateau, especially in the southern and southwestern prefectures, and has the highest incidence of malaria in China [5]. It is characterized by a high incidence of hemoglobin variants [6]. Among the 56 recognized ethnic groups in China, twenty-six are found in Yunnan. The total population of Yunnan includes 46 million people and consists of many ethnic groups. Two-thirds are of the Han ethnic group (32 million), and the remaining population of 14 million consists of 25 different ethnic groups including Yi (11%), Hani (3.5%), Bai (3.4%), Dai (2.6%), Zhuang (2.6%) and others (national census in 2011). Identification of β-globin gene mutations in the different regions will be helpful to explain the heterogeneity and prevalence of β-thalassemia in different ethnic regions. Moreover, the heterogeneity of these mutations can be used as genetic references to elucidate historical migrations and anthropological origins. The aim of this retrospective study, undertaken in the 16 prefecture-level divisions of Yunnan, was to determine the heterogeneity of thalassemia in different ethnic groups. To our knowledge, this is the first report on β-thalassemia mutations associated with the ethnic and regional variations in southwestern China. The results modify and expand the previously reported genetic information related to β-thalassemia in China.

Materials and Methods

Study Population and Detection of β-globin Mutations

From 2004 to 2014, a total of 1,441 individuals (aged 1–56 years) who were residents of Yunnan province were enrolled in the study. Hematological and clinical data associated with β-thalassemia obtained during genetic counseling, prenatal diagnosis and screening programs (programs conducted in the First Peoples’ Hospital of Yunnan Province, Peoples’ Hospital of Dehong, Maternal and Child Health Hospital of Wenshan, Maternal and Child Health Hospital of Xishuangbanna, Maternal and Child Health Hospital of Dehong, Maternal and Child Health Hospital of Lijiang) were analyzed. Blood samples were obtained for molecular analysis at either the First Peoples’ Hospital of Yunnan Province or the Peoples’ Hospital of Dehong Autonamic Prefecture of Dai and Jingpo. Clinical data were obtained from medical records of the patients and informed consent was signed by the participants or their guardians. The protocol and consent information for this study were approved by the Medical Ethics Committee of the First Peoples’ Hospital of Yunnan Province, PRC. Venous blood samples were collected in tubes with EDTA from hematological phenotype positive carriers and patients. A total of 17 β-globin mutations frequently seen in the Chinese population were detected by PCR-reverse dot blot (RDB) assays as previously described [7]. The entire β-globin gene, from the 5' promoter region to the 3' untranslated region (3' UTR), were sequenced in cases that did not have any of the 17 common mutations or in cases in which the genotype disagreed with the phenotype according to a previous report [7].

Haplotype Analysis of the β-Globin Gene Cluster

Haplotypes throughout the β-globin gene cluster were determined by PCR-RFLP methodology and family linkage analysis as previously described [8]. The polymorphic sites were the following: 5′ to ε gene by Hind II, within IVS-II of the Gγ and Aγ genes by Hind III, within and 3′ to ψβ by Hind II, IVS-II of the β gene by Ava II and 3′ to the β gene by BamH I.

Results

β-Globin Mutations Identified in Yunnan

Eighteen β-globin gene mutations and seven hemoglobin variants were identified in 1,616 alleles included in the study (1,616 β-globin mutations in 2,882 alleles). Of the 1,441 subjects investigated, 175 were compound heterozygous or homozygous for β-globin mutations. Four rare β-globin mutations were detected for the first time in China; i.e., Hb Dieppe, CD 127 (A>G) (HBB:c.383A>G); initiation CD (T>C) (HBB:c.2T>C); Hb G-Copenhagen, CD 47 (G>A) (HBB:c.142G>A) and CD 5(-CT) (HBB:c.17_18delCT). The second cases of Hb G-Coushatta, CD 22 (A>C) (HBB:c.68A>C) [9] and CD 121 (G>T) (HBB:c.364G>T) [10] in mainland China were found in our study. The data were also analyzed according to five regions of Yunnan (Table 1 and Table 2), showing 406 (25.12%, 406/1616) alleles were found in the central region (Kunming, Yuxi, Chuxiong), 59 (3.65%, 59/1616) alleles were found in the northeast region (Zhaotong, Qujing), 63 (3.90%, 63/1616) alleles were found in the northwest region (Dali, Lijiang, Nujiang, Shangri-La), 815 (50.43%, 815/1616) alleles were found in the southwest region (Baoshan, Dehong, Xishuangbanna, Lincang, Puer) and 273 (16.90%, 273/1613) alleles were found in the southeast region (Wenshan, Honghe). The distribution pattern of β-globin gene mutations in 22 different ethnic groups (including one Khmer from Cambodia and four Shan from Myanmar) from all 16 prefecture-level divisions is also represented in Table 2 and Table 3. The frequency of Hb E (CD 26, G>A) (HBB:c.79G>A) was strikingly high in some minorities such as the Dai (60.13%, 353/587, Table 3) and CD 17 (A>T) (HBB:c.52A>T) was the most common mutation in the Zhuang minority (48.89%, 66/135, Table 3).
Table 1

Number of β-globin mutations found in five regions of Yunnan.

Mutation Type Center Northeast Northwest Southeast Southwest Total
CD 26 (G>A) (HBB:c.79G>A)β+ 103144334535729 (45.1%)
CD 17 (A>T) (HBB:c.52A>T)β0 100173107110337 (20.9%)
CD 41–42 (–TCTT) (HBB:c.126_129delCTTT)β0 8418891130331 (20.5%)
IVS-II-654 (C>T) (HBB:c.316-197C>T)β+ 78551716121 (7.49%)
CD 71/72 (+A) (HBB:c.216_217insA)β0 81-71632 (1.98%)
–28 (A>G) (HBB:c.-78A>C)β+ 111112631 (1.92%)
CD 27/28 (+C) (HBB:c.84_85insC)β0 512-19 (0.56%)
IVS-I-1 (G>T) (HBB:c.92+1G>T)β0 1--2-3 (0.19%)
CD 113 (T>A) (HBB:c.341T>A)HbVar3----3 (0.19%)
CD 121 (G>C) (HBB:c.364G>C)HbVar1-1--2 (0.12%)
IVS-I-5 (G>C) (HBB:c.92+5G>C)β+ 1---12 (0.12%)
-29 (A>G) (HBB:c.-79A>G)β+ 1--1-2 (0.12%)
CD 43 (G>T) (HBB:c.130G>T)β0 -1-1-2 (0.12%)
CD 56 (G>A) (HBB:c.170G>A)HbVar1----1 (0.06%)
IVS-I-2 (T>C) (HBB:c.92+2T>C)β0 1----1 (0.06%)
–31 (A>C) (HBB:c.-81A>G)β+ -1---1 (0.06%)
CD 5 (–CT) (HBB:c.17_18delCT)β0 ---1-1 (0.06%)
CD 22 (A>G) (HBB:c.68A>G)HbVar1----1 (0.06%)
CD 59 (G>C) (HBB:c.180G>C)HbVar1----1 (0.06%)
CD 121 (G>T) (HBB:c.364G>T)β0 1----1 (0.06%)
CD 47 (G>A) (HBB:c.142G>A)HbVar1----1 (0.06%)
CD 22 (A>C) (HBB:c.68A>C)HbVar1----1 (0.06%)
CD 127 (A>G) (HBB:c.383A>G)β0 1----1 (0.06%)
Initiation CD (T>C) (HBB:c.2T>C)β0 1----1 (0.06%)
CAP +40 to +43 (-AAAC) (HBB:c.-11_-8delAAAC)β+ 1----1 (0.06%)
Total406 (25.12%)59 (3.65%)63 (3.90%)273 (18.9%)815 (50.4%)1616 (100%)

β0: production of β-globin chain is entirely eliminated; β+: production of β-globin chain is reduced; HbVar: hemoglobin variant.

Table 2

Number of alleles form 22 different ethnic groups in five regions of Yunnan.

Ethnicity Center Northeast Northwest Southeast Southwest Total
Han336512791129634(39.2%)
Dai10--3574587(36.3%)
Zhuang10--125-135(8.35%)
Yi222433566(4.08%)
Bai2-20-527(1.67%)
Achang----2727(1.67%)
Jingpo---12627(1.67%)
Lisu2-4-1521(1.30%)
Hui9232218(1.11%)
Miao41-8-13(0.80%)
Deang----1313(0.80%)
Hani1--2710(0.62%)
Buyi52-119(0.56%)
Yao---718(0.50%)
Naxi2-5--7(0.43%)
Shan1---45(0.25%)
Jinuo----33(0.19%)
Wa----22(0.12%)
Shui-1---1(0.06%)
Lafu----11(0.06%)
Khmer1----1(0.06%)
Dong1----1(0.06%)
Total40659632738151616

One Khmer come from Cambodia, lived in Kunming; Four Shan come from Myanmar, one lived in Kunming and three lived in Dehong.

Table 3

The frequency of β-thalassemia mutations in different ethnic populations.

MinorityCD 26 (G>A)CD 17 (A>T)CD 41–42 (–TCTT)IVS-II-654 (C>T)CD 71/72 (+A)–28 (A>G)Others A Total
Han20014213797111730634
Dai3538811971451587
Zhuang366532632135
Yi34144516266
Bai2034----27
Achang27------27
Jingpo27------27
Lisu201-----21
Hui9513---18
Miao-1021---13
Deang13------13
Others B 238116---48
Total7293373311213231351616

A: other 12 β-thalassemia mutations and 7 hemoglobin variants mutations;

B: other minority ethnic groups, including Hani, Yao, Buyi, Naxi, Dong, Shui, Wa, Jinuo, Lafu, Khmer and Shan.

β0: production of β-globin chain is entirely eliminated; β+: production of β-globin chain is reduced; HbVar: hemoglobin variant. One Khmer come from Cambodia, lived in Kunming; Four Shan come from Myanmar, one lived in Kunming and three lived in Dehong. A: other 12 β-thalassemia mutations and 7 hemoglobin variants mutations; B: other minority ethnic groups, including Hani, Yao, Buyi, Naxi, Dong, Shui, Wa, Jinuo, Lafu, Khmer and Shan.

Prevalence of β-Thalassemia in the Center of Yunnan

In the center of Yunnan, Hb E (CD 26, G>A) (HBB:c.79G>A) (25.4%, 103/406), CD 17 (A>T) (HBB:c.52A>T) (24.63%, 100/406), CD 41–42 (-TCTT) (HBB:c.126_129delCTTT) (20.69%, 84/406) and IVS-II-654 (C>T) (HBB:c.316-197C>T) (19.21%, 78/406) mutations were the most frequent (Table 1 and Fig 1). The majority of β-globin gene mutations screened in this region were found in the Han ethnic group (82.76%, 336/406) while 5.42% were in the Yi ethnic group (22/406), 2.46% (10/406) were in the Zhuang ethnic group and 2.22% (9/406) were in the Muslim (Hui) ethnic group (Table 2). Direct sequencing identified a number of rare mutations, including Hb Dieppe, CD 127 (A>G) (HBB:c.383A>G); initiation CD (T>C) (HBB:c.2T>C); Hb G-Copenhagen, CD 47 (G>A) (HBB:c.142G>A); Hb G-Coushatta, CD 22 (A>C) (HBB:c.68A>C); CD 121 (G>T) (HBB:c.364G>T); Hb D-Los Angeles, CD121 (G>C) (HBB:c.364G>C); Hb G-Taipei, CD 22 (A>G) (HBB:c.68A>G); Hb New York, CD 113 (T>A) (HBB:c.341T>A); Hb J-Bangkok, CD 56 (G>A) (HBB:c.170G>A); Hb J-Lome, CD 59 (G>C) (HBB:c.180G>C) and IVS-I-2 (T>C) (HBB:c.92+2T>C) (Table 1).
Fig 1

Geographic distribution of β-thalassemia mutations in five regions of Yunnan.

A: northwester Yunnan; B: central Yunnan; C: northeastern Yunnan; D: southwestern Yunnan; E: southeastern Yunnan.

Geographic distribution of β-thalassemia mutations in five regions of Yunnan.

A: northwester Yunnan; B: central Yunnan; C: northeastern Yunnan; D: southwestern Yunnan; E: southeastern Yunnan.

Prevalence of β-Thalassemia in Southern Yunnan

Analysis of 815 alleles from the southwestern region showed that the most common mutations were Hb E (CD 26, G>A) (HBB:c.79G>A) (65.64%, 535/815), CD 41–42 (-TCTT) (HBB:c.126_129delCTTT) (15.95%, 130/815), CD 17 (A>T) (HBB:c.52A>T) (13.50%, 110/815), CD 71–72 (+A) (HBB:c.216_217insA) (1.96%, 16/815) and IVS-II-654 (C>T) (HBB:c.316-197C>T) (1.96%, 16/815), which were found in 99.02% (807/815) of the β-globin genes in this region (Table 1 and Fig 1). Among the patients screened in this area, 157 were β-thalassemia/Hb E or Hb E homozygous. Chromosomes screened in this area were mainly from the Dai ethnic group (70.43%, 574/815) and the remainder were from the 11 different ethnic groups (15.83% Han, 3.31% Achang, 3.19% Jingpo, 1.84% Lisu and others; Table 2). The Hb E (CD 26, G>A) mutation was highly prevalent in almost all of the southwestern populations that were screened and was especially prevalent in Achang (100%, 27/27), Jingpo (100%, 26/26) and Deang (100%, 13/13; Table 3). In the southeast region, the most common mutations were CD 17 (A>T) (HBB:c.52A>T) (39.19%, 107/273), followed by CD 41–42 (-TCTT) (HBB:c.126_129delCTTT) (33.33%, 91/273), Hb E (CD 26, G>A) (HBB:c.79G>A) (12.45%, 34/273) and IVS-II-654 (C>T) (HBB:c.316-197C>T) (6.23%, 17/273) (Table 1 and Fig 1). Six other mutations were identified and all were at a frequency of less than 9%. Most of the alleles screened were found in the minority populations, including the Zhuang (45.79%, 125/273), Yi (12.09%, 33/273), Miao (2.93%, 8/273) and others.

Prevalence of β-Thalassemia in Northern Yunnan

In the northeast region, the most common mutations were CD 41–42 (-TCTT) (HBB:c.126_129delCTTT) (30.50%, 18/59) and CD 17 (A>T) (HBB:c.52A>T) (28.81%, 17/59). In the northwest region, the most common mutations were Hb E (CD 26, G>A) (HBB:c.79G>A) (68.25%, 43/63), CD 41–42 (-TCTT) (HBB:c.126_129delCTTT) (12.70%, 8/63), IVS-II-654 (C>T) (HBB:c.316-197C>T) (7.94%, 5/63) and CD 17 (A>T) (HBB:c.52A>T) (4.76%, 3/63; Table 1 and Fig 1).

β-Thalassemia Mutation Associations in Haplotypes

Haplotype analysis for 41 unrelated thalassemia chromosomes associated with seven mutations were analyzed (Table 4). Seven different haplotypes were identified including haplotype I (9), haplotype III (4), haplotype IV (2), haplotype V (3), haplotype VII (19),- - - - - + + (atypical haplotype, 3) and - - + - - - + (atypical haplotype, 1).
Table 4

β-thalassemia mutations and their haplotypes in the Yunnan population.

Mutation Origin and Minority Haplotype
CD 41–42 (–TCTT)Xishuangbanna, Dai (3); Wenshan, Han (2); Kunming, Han (1)+ - - - - - + (VII)
Xishuangbanna, Dai (1)+ - - - - + - (V)
Xishuangbanna, Dai (3)- - - - - + + A
Qujing, Han (1), Wenshan, Yao (2); Chuxiong, Han (1); Xishuangbanna, Dai (1)+ - - - - + + (I)
CD 17 (A>T)Chuxiong, Han (1); Yuxi, Dai (2); Kunming, Han (2); Kunming, Zhuang (1); Dali,Yi (1); Zhaotong, Han (1); Xishuangbanna, Dai (2)+ - - - - - + (VII)
Wenshan, Han (1)- + - + + - + (IV)
CD 26 (G>A)Chuxiong, Han (1); Dehong, Dai (2); Xishuangbanna, Dai (1)- + - + + + - (III)
Puer, Han (2)+ - - - - + - (V)
CD 47 (G>A)Kunming, Han (1)- - + - - - + B
IVS-II-654 (C>T)Kunming, Buyi (1); Kunming, Han (1); Chuxiong, Han (1); Wenshan, Yi(1)+ - - - - + + (I)
IVS-I-1 (G>T)Wenshan, Han (1)+ - - - - - + (VII)
CD 71/72 (+A)Kunming, Han (1); Yuxi, Dai (1)+ - - - - - + (VII)
CD 27/28 (+C)Xishuangbanna, Han (1)- + - + + - + (IV)

A and B: atypical haplotype.

A and B: atypical haplotype.

Discussion

This is the first study on β-thalassemia carriers and other hemoglobinopathies covering 22 different ethnic groups from different regions of Yunnan. Knowledge of the geographic and ethnic distributions of β-thalassemia mutations has useful implications for the prevention and control of thalassemia in China. The data indicated that there were marked differences in the geographical distributions of β-thalassemia mutations within different racial groups, highlighting the ethnic diversity in Yunnan. Hb E (CD 26, G>A) (65.64%) and CD 41–42 (-TCTT) (30.5%) were the most prevalent mutations in the southwest and northeast regions, respectively, whereas CD 17 (A>T) (39.19%) was the most common mutation in the southeastern Yunnan population. In the southeastern region, in which Zhuang is the largest group (45.79%), CD 17 (A>T) (39.19%) was the most common mutation followed by CD 41–42 (-TCTT) (33.33%). This situation was similar to the frequency of β-thalassemia in the neighboring Guangxi Zhuang autonomous region, where the most common mutation was CD 41–42 (-TCTT) (39.4%) and CD 17 (A>T) (32%) [11]. Hb E (CD 26, G>A) (65.64%) and CD 41–42 (-TCTT) (15.95%) were the most prevalent mutations in the southwestern region, especially for the Dai minority group (70.43%), which was similar to the Thai population in Thailand [12-14]. The Thai population includes immigrants of the ancestors of the present-day Dai people from Yunnan [15]. In the southwest region, Hb E (CD 26, G>A) (65.64%) was the most common mutation observed in the local minority groups, especially for the native people who live in the tropical plateau; i.e., Achang (100%), Jingpo (100%) and Deang (100%), which has not been reported in other populations in China. The high frequency of Hb E (CD 26, G>A) in this region was similar to that of adjacent countries, such as Myanmar [16], Thailand and Laos [13], where a “hot spot” of Hb E (CD 26, G>A) is located on the Thai-Laos-Cambodia border [17]. A plausible explanation for the high incidence of Hb E (CD 26, G>A) was that carriers of Hb E (CD 26, G>A) were protected against falciparum malaria [18]. The geographical distribution of Hb E (CD 26, G>A) in Yunnan co-exists with the distribution of previous malaria epidemics [19], suggesting that the high frequency of Hb E might be associated with natural selective inhibition of malaria [20]. Secondly, it may be due to high consanguinity in minority groups with very restricted population movement caused by sociocultural factors and difficult travel potential associated with being surrounded by large mountains, which increases the risks of β-thalassemia/Hb E compound heterozygosity and Hb E homozygosity. In the center region, where many different ethnic groups (14 ethnic groups in this study) reside, representing nearly 12 million habitants, genetic heterogeneity has led to a admixture of different β-thalassemia mutations. A total of 22 β-globin mutations, including 3 mutations that have not been reported previously in China, were detected in the 406 alleles, which accounted for two-fifths of the β-thalassemia mutations reported in China. Hb E (CD 26, G>A) (25.4%) and CD 17 (A>T) (24.6%) were the most common mutations. Among the mutations that were identified, CD 127 (A>G) was a very rare dominant β-thalassemia mutation first discovered in a 31-year-old French female 21 years ago [21]. Initiation CD (T>C) was observed in Yugoslavia in 1990 [22], but never in China. CD 47 (G>A) was a rare mutation detected in Danish, Sicilian and families with African ancestry [23]. The heterogeneity of β-thalassemia in this region might be due to the fact that the center of Yunnan, as a capital ruled by Yi, Mongols and Han people throughout history, is a crucial strategic crossroad between China and southern Asia. Also, the Japanese invasion (1940 AD) forced various immigrants into this region. Centuries of influx of many people resulted in great heterogeneity in the population. It has been suggested that the common mutations may be indigenous to the native population of Yunnan, whereas the rare β-globin mutations may have been introduced by immigration. In the present study, seven types of haplotypes were found in 41 β-thalassemic chromosomes. Haplotype VII (+ - - - - - +, 19 chromosomes) and haplotype I (+ - - - - + +, 9 chromosomes) were the most prevalent haplotypes among β-thalassemia patients. The findings revealed that the haplotype VII (+ - - - - - +) accounted for 90.9% (10/11) of the CD 17 (A>T) alleles examined. This linkage was similar to the results of surveys carried out in India [24], Korean [25] and South Vietnam [26]. IVS-II-654 (C>T) was linked to only one type of haplotype: + - - - - + + (haplotype I) and haplotype I in association with IVS-II-654 (C>T) has been previously reported in China [6] and Indonesia [27]. The mutation CD 41–42 (-TCTT) was associated mainly with + - - - - - + (haplotype VII) and + - - - - + + (haplotype I), which had been described earlier in southern China [28-29]. The haplotype background associated with Hb E (CD 26, G>A) was mainly - + - + + + - (haplotype III), which was similar to that found in patients from the eastern region of India [30]. It was identified for the first time that Hb G-Copenhagen (CD 47, G>A) was associated with the haplotype - - + - - - +, a rare haplotype seldomly reported in β-thalassemia patients in China. The remaining patients had haplotype IV, haplotype V and - - - - - + + (atypical haplotype). Our study has shown the remarkable diversity of β-thalassemia in different geographic regions in Yunnan. This information on the epidemiology of hemoglobin disorders could be helpful for planning appropriate treatments for β-thalassemia patients according to different population groups. Until now, there have been few studies regarding β-thalassemia carriers in minority groups and the evolution of haplotypes of the β-hemoglobin gene. Our study provided useful information to pave the way for prenatal diagnosis programs and large-scale population screening for β-thalassemia in Yunnan.
  29 in total

1.  Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China.

Authors:  F Xiong; M Sun; X Zhang; R Cai; Y Zhou; J Lou; L Zeng; Q Sun; Q Xiao; X Shang; X Wei; T Zhang; P Chen; X Xu
Journal:  Clin Genet       Date:  2010-04-19       Impact factor: 4.438

2.  Genotyping of beta thalassemia trait by high-resolution DNA melting analysis.

Authors:  Rattika Saetung; Siriwan Ongchai; Pimlak Charoenkwan; Torpong Sanguansermsri
Journal:  Southeast Asian J Trop Med Public Health       Date:  2013-11       Impact factor: 0.267

3.  The spectrum of α- and β-thalassemia mutations in Yunnan Province of Southwestern China.

Authors:  Jie Zhang; Bao-Sheng Zhu; Jing He; Xiao-Hong Zeng; Jie Su; Xiang-Hu Xu; Su-Yun Li; Hong Chen; Ying-Hong Zhang
Journal:  Hemoglobin       Date:  2012       Impact factor: 0.849

4.  Molecular epidemiological survey of hemoglobinopathies in the Wuxi region of Jiangsu Province, eastern China.

Authors:  Min Lin; Zhi-Jun Han; Qian Wang; Lei Zheng; Yan Wang; Hui Yang; Yue Huang; Fen Lin; Xiao-Fen Zhan; Chun-Ping Lin; Jiao-Ren Wu; Zhao-Yun Luo; Jing-Bo Liu; Zhi-He Yan; Shu-Yan Zheng; Jia-Kun Zheng; Min Lu; Juan-Juan Zhu; Long-Xu Xie; Li-Ye Yang
Journal:  Hemoglobin       Date:  2013-06-27       Impact factor: 0.849

5.  The spectrum of α- and β-thalassemia mutations of the Li people in Hainan Province of China.

Authors:  Hongxia Yao; Xinping Chen; Lie Lin; Congming Wu; Xiangjun Fu; Hua Wang; Zhiming Yao; Wenting Chen; Li Huang; Ruimei Tang; Ruo Rao; Suwen Wang; Yipeng Ding
Journal:  Blood Cells Mol Dis       Date:  2014-02-16       Impact factor: 3.039

6.  Spatial patterns of malaria reported deaths in Yunnan Province, China.

Authors:  Yan Bi; Wenbiao Hu; Henling Yang; Xiao-Nong Zhou; Weiwei Yu; Yuming Guo; Shilu Tong
Journal:  Am J Trop Med Hyg       Date:  2012-12-26       Impact factor: 2.345

7.  Spectrum of β-thalassemia mutations in Guizhou Province, PR China, including first observation of codon 121 (GAA>TAA) in Chinese population.

Authors:  Sheng-Wen Huang; Xing-Mei Liu; Gui-Fang Li; Li Su; Xian Wu; Ru-Lei Wang
Journal:  Clin Biochem       Date:  2013-09-27       Impact factor: 3.281

8.  α-Thalassemia impairs the cytoadherence of Plasmodium falciparum-infected erythrocytes.

Authors:  Michael A Krause; Seidina A S Diakite; Tatiana M Lopera-Mesa; Chanaki Amaratunga; Takayuki Arie; Karim Traore; Saibou Doumbia; Drissa Konate; Jeffrey R Keefer; Mahamadou Diakite; Rick M Fairhurst
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  The prevalence and molecular spectrum of α- and β-globin gene mutations in 14,332 families of Guangdong Province, China.

Authors:  Aihua Yin; Bing Li; Mingyong Luo; Longchang Xu; Li Wu; Liang Zhang; Yuanzhu Ma; Tingting Chen; Shuang Gao; Juqing Liang; Hao Guo; Danqing Qin; Jicheng Wang; Tenglong Yuan; Yixia Wang; Wei-wei Huang; Wen-Fei He; Yanxia Zhang; Chang Liu; Sujian Xia; Qingshan Chen; Qingguo Zhao; Xiaozhuang Zhang
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

10.  Predicting future blood demand from thalassemia major patients in Hong Kong.

Authors:  Eric H Y Lau; Xiu-Qing He; Cheuk-Kwong Lee; Joseph T Wu
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more
  11 in total

1.  Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China.

Authors:  Jing He; Wenhui Song; Jinlong Yang; Sen Lu; Yuan Yuan; Junfu Guo; Jie Zhang; Kai Ye; Fan Yang; Fangfang Long; Zhiyu Peng; Haijing Yu; Le Cheng; Baosheng Zhu
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

2.  Mutation screening for thalassaemia in the Jino ethnic minority population of Yunnan Province, Southwest China.

Authors:  Shiyun Wang; Rong Zhang; Guangxin Xiang; Yang Li; Xuhong Hou; Fusong Jiang; Feng Jiang; Cheng Hu; Weiping Jia
Journal:  BMJ Open       Date:  2015-12-29       Impact factor: 2.692

3.  Haematological and electrophoretic characterisation of β-thalassaemia in Yunnan province of Southwestern China.

Authors:  Jie Zhang; Jing He; Xiaoqin Mao; Xiaohong Zeng; Hong Chen; Jie Su; Baosheng Zhu
Journal:  BMJ Open       Date:  2017-01-31       Impact factor: 2.692

4.  Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing.

Authors:  Yue Zhao; Yue Feng; Xiaoxue Ding; Shuwei Dong; Hong Zhang; Jiahuan Ding; Xueshan Xia
Journal:  Int J Mol Med       Date:  2017-05-11       Impact factor: 4.101

5.  β-globin gene cluster haplotypes in ethnic minority populations of southwest China.

Authors:  Hao Sun; Hongxian Liu; Kai Huang; Keqin Lin; Xiaoqin Huang; Jiayou Chu; Shaohui Ma; Zhaoqing Yang
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

6.  Analysis of deletional hereditary persistence of fetal hemoglobin/δβ-thalassemia and δ-globin gene mutations in Southerwestern China.

Authors:  Jie Zhang; Yang Yang; Peng Li; Yuanlong Yan; Tao Lv; Tingting Zhao; Xiaohong Zeng; Dongmei Li; Xiaoyan Zhou; Hong Chen; Jie Su; Tonghua Yang; Jing He; Baosheng Zhu
Journal:  Mol Genet Genomic Med       Date:  2019-05-01       Impact factor: 2.183

7.  Molecular epidemiology, pathogenicity, and structural analysis of haemoglobin variants in the Yunnan province population of Southwestern China.

Authors:  Jie Zhang; Peng Li; Yang Yang; Yuanlong Yan; Xiaohong Zeng; Dongmei Li; Hong Chen; Jie Su; Baosheng Zhu
Journal:  Sci Rep       Date:  2019-06-04       Impact factor: 4.379

8.  A Cross-Sectional Study of Detection of Beta Globin (HBB) Haplotypes Among Beta Thalassemia Patients.

Authors:  Ali Alsamiri; Fatma Alzahrani; Najlaa Filimban; Ammar Khojah; Raed Felimban; Talal Qadah
Journal:  Cureus       Date:  2021-02-16

9.  Five novel globin gene mutations identified in five Chinese families by next-generation sequencing.

Authors:  Jie Zhang; Meijuan Xie; Zhiyu Peng; Xiaoyan Zhou; Tingting Zhao; Chanchan Jin; Yuanlong Yan; Xiaohong Zeng; Dongmei Li; Yangjia Zhang; Jie Su; Na Feng; Jing He; Xiangmei Yao; Tao Lv; Baosheng Zhu
Journal:  Mol Genet Genomic Med       Date:  2021-10-28       Impact factor: 2.183

10.  β‑thalassemia caused by compound heterozygous mutations and cured by bone marrow transplantation: A case report.

Authors:  Liusong Wu; Zhiyu Peng; Sen Lu; Mei Tan; Ying Rong; Runmei Tian; Yuhang Yang; Yan Chen; Jindong Chen
Journal:  Mol Med Rep       Date:  2017-09-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.